Matrine-loaded self-adhesive swelling microneedle for inflammation regulation to improve eczema treatment

Abstract

Eczema is a common chronic dermatological disease. Conventional treatments exhibit limited efficacy due to fast drug release resulting in short-term relief. Development of a new treatment strategy that enables sustained drug release and long-term maintenance on the skin surface is necessary. A self-adhesive swelling microneedle patch (SDSMNs) was designed and constructed using a two-step casting method. The adhesive substrate was prepared by blending gelatin and dopamine via oxidation of NaIO₄, so it could adhere onto the skin surface as well as withstand repeated bending movement without detachment. The swelling needles were fabricated using polyvinyl alcohol (PVA) and polyvinylpyrrolidone (PVP), which could swell by absorbing interstitial fluid and release the drug in a controlled manner. SDSMNs also showed desirable antibacterial activities toward E. coli and S. aureus. The adhesive microneedles loaded with matrine (MAT-SDSMNs), an anti-inflammatory Chinese medicine, dramatically relieved eczema symptoms through IL-17 mediated inflammation responses. The use of MAT-SDSMNs significantly decreased the infiltration of inflammation cells and level of inflammatory cytokines, reduced the skin thickness, and increased collagen deposition fraction compared with conventional ointment or subcutaneous injection. The results suggested that MAT-SDSMNs can improve eczema treatment by regulating the local inflammatory microenvironment, providing a simple, self-administered sustainable strategy for eczema treatment.

Keywords

Self-adhesive swelling microneedle / Eczema / Matrine / Inflammation regulation

References

[] Ahmad SF, Zoheir KMA, Ansari MA, Nadeem A, Bakheet SA, AL-Ayadhi LY, Alzahrani MZ, Al-Shabanah OA, Al-Harbi MM, Attia SM. Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism. Mol Neurobiol, 2017, 54: 4390-4400,

[] Andersen RM, Thyssen JP, Maibach HI. Qualitative vs quantitative atopic dermatitis criteria - in historical and present perspectives. J Eur Acad Dermatol, 2016, 30: 604-618,

[] Azizi G, Rastegar Pouyani M, Navabi SS, Yazdani R, Kiaee F, Mirshafiey A. The newly identified T helper 22 cells lodge in leukemia. Int J Hematol Oncol Stem Cell Res, 2015, 9: 143-154, pmcid: 4529682

[] Carello R, Ricottini L, Miranda V, Panei P, Rocchi L, Arcieri R, Galli E. Long-term treatment with low-dose medicine in chronic childhood eczema. A double-blind two-stage randomized control trial. Ital J Pediatr, 2017, 72: 312-312

[] Dourmishev LA, Mironova NY. Atopic dermatitis: from etiology and history to treatment. Acta Medica Bulgarica, 2021, 48: 68-76,

[] Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, Berger TG, Bergman JN, Cohen DE, Cooper KD, Cordoro KM, Davis DM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Silverman RA, Williams HC, Elmets CA, Block J, et al.. Guidelines of care for the management of atopic dermatitis section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol, 2014, 70: 338-351,

[] Flohr C, Mann J. New insights into the epidemiology of childhood atopic dermatitis. Allergy, 2014, 69: 3-16,

[] Gómez-Guillén MC, Pérez-Mateos M, Gómez-Estaca J, López-Caballero E, Giménez B, Montero P. Fish gelatin: a renewable material for developing active biodegradable films. Trends Food Sci Tech, 2009, 20: 3-16,

[] Gowda AHJ, Bu Y, Kudina O, Krishna KV, Bohara RA, Eglin D, Pandit A. Design of tunable gelatin-dopamine based bioadhesives. Int J Biol Macromol, 2020, 164: 1384-1391,

[] Heo WI, Lee KE, Hong JY, Kim MN, Oh MS, Kim YS, Kim KW, Kim KE, Sohn MH. The role of interleukin-17 in mouse models of atopic dermatitis and contact dermatitis. Clin Exp Dermatol, 2015, 40: 665-671,

[] Herjan T, Hong L, Bubenik J, Bulek K, Qian W, Liu C, Li X, Chen X, Yang H, Ouyang S, Zhou H, Zhao J, Vasu K, Cockman E, Aronica M, Asosingh K, Licatalosi DD, Qin J, Fox PL, Hamilton TA, et al.. IL-17-receptor-associated adaptor Act1 directly stabilizes mRNAs to mediate IL-17 inflammatory signaling. Nat Immunol, 2018, 19: 354-365, pmcid: 6082628

[] Hofmann MA, Kiecker F, Zuberbier T. A systematic review of the role of interleukin-17 and the interleukin-20 family in inflammatory allergic skin diseases. Curr Opin Allergy Cl, 2016, 16: 451-457,

[] Hofmann MA, Fluhr JW, Ruwwe-Glösenkamp C, Stevanovic K, Bergmann KC, Zuberbier T. Role of IL-17 in atopy-A systematic review. Clin Transl Allergy, 2021, 11: e12047, pmcid: 8361814

[] Homey B, Dieu-Nosjean MC, Wiesenborn A, Massacrier C, Pin JJ, Oldham E, Catron D, Buchanan ME, Müller A, Malefyt RD, Deng G, Orozco R, Ruzicka T, Lehmann P, Lebecque S, Caux C, Zlotnik A. Up-regulation of macrophage inflammatory protein-3α/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol, 2000, 164: 6621-6632,

[] Kang GJ, Han SC, Yi EJ, Kang HK, Yoo ES. The inhibitory effect of premature citrus unshiu extract on atopic dermatitis in vitro and in vivo. Toxicol Res, 2011, 27: 173-180, pmcid: 3834378

[] Kim YE, Choi SW, Kim MK, Nguyen TL, Kim J. Therapeutic hydrogel patch to treat atopic dermatitis by regulating oxidative stress. Nano Lett, 2022, 22: 2038-2047,

[] Mandlik DS, Mandlik SK. Atopic dermatitis: new insight into the etiology, pathogenesis, diagnosis and novel treatment strategies. Immunopharm Immunot, 2021, 43: 105-125,

[] Martinovich VP, Baradzina KU. Peptide hormones in medicine: a 100-year history. Russ J Bioorg Chem, 2022, 48: 221-232,

[] Montazerian H, Baidya A, Haghniaz R, Davoodi E, Ahadian S, Annabi N, Khademhosseini A, Weiss PS. Stretchable and bioadhesive gelatin methacryloyl-based hydrogels enabled by dopamine polymerization. Acs Appl Mater Inter, 2021, 13: 40290-40301,

[] Nguyen PM, Putoczki TL, Ernst M. STAT3-activating cytokines: a therapeutic opportunity for inflammatory bowel disease?. J Interf Cytok Res, 2015, 35: 340-350,

[] Noda S, Krueger JG, Guttman-Yassky E. The translational revolution and use of biologics in patients with inflammatory skin diseases. J Allergy Clin Immun, 2015, 135: 324-336,

[] Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab, 2015, 66: 8-16,

[] Puig L. The role of IL 23 in the treatment of psoriasis. Expert Rev Clin Immunol, 2017, 13: 525-534,

[] Shi Y, Zhao JX, Li H, Yu M, Zhang WX, Qin D, Qiu KJ, Chen XG, Kong M. A drug-free, hair follicle cycling regulatable, separable, antibacterial microneedle patch for hair regeneration therapy. Adv Healthc Mater, 2022, 11: e2200908,

[] Sun XY, Jia LY, Rong Z, Zhou X, Cao LQ, Li AH, Guo M, Jin J, Wang YD, Huang L, Li YH, He ZJ, Li L, Ma RK, Lv YF, Shao KK, Zhang J, Cao HL. Research advances on matrine. Front Chem, 2022, 10: 867318, pmcid: 9010661

[] Wang AX, Landén NX. New insights into T cells and their signature cytokines in atopic dermatitis. IUBMB Life, 2015, 67: 601-610,

[] Weidinger S, Novak N. Atopic dermatitis. Lancet, 2016, 387: 1109-1122,

[] Yang H, Wu X, Zhou Z, Chen X, Kong M. Enhanced transdermal lymphatic delivery of doxorubicin via hyaluronic acid based transfersomes/microneedle complex for tumor metastasis therapy. Int J Biol Macromol, 2019, 125: 9-16,

[] Zhang H, Chen LL, Sun XP, Yang QJ, Wan LL, Guo C. Matrine: a promising natural product with various pharmacological activities. Front Pharmacol, 2020, 11: 588, pmcid: 7232545

[] Zhou ZZ, Pang JH, Wu XJ, Wu W, Chen XG, Kong M. Reverse immune suppressive microenvironment in tumor draining lymph nodes to enhance anti-PD1 immunotherapy via nanovaccine complexed microneedle. Nano Res, 2020, 13: 1509-1518,